BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30018251)

  • 1. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion.
    Sharifi-Rad M; Fokou PVT; Sharopov F; Martorell M; Ademiluyi AO; Rajkovic J; Salehi B; Martins N; Iriti M; Sharifi-Rad J
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30018251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemicals in
    Salehi B; Sharopov F; Martorell M; Rajkovic J; Ademiluyi AO; Sharifi-Rad M; Fokou PVT; Martins N; Iriti M; Sharifi-Rad J
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into the anti-ulcerogenic potentials of medicinal herbs and their bioactive metabolites.
    Shipa SJ; Khandokar L; Bari MS; Qais N; Rashid MA; Haque MA; Mohamed IN
    J Ethnopharmacol; 2022 Jul; 293():115245. PubMed ID: 35367330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment.
    Xie JH; Chen YL; Wu QH; Wu J; Su JY; Cao HY; Li YC; Li YS; Liao JB; Lai XP; Huang P; Su ZR
    BMC Complement Altern Med; 2013 May; 13():119. PubMed ID: 23721522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and peptic ulcer disease.
    Feldman M; Peterson WL
    West J Med; 1993 Nov; 159(5):555-9. PubMed ID: 8279151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
    Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
    J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tannins, peptic ulcers and related mechanisms.
    De Jesus NZT; Falcão HS; Gomes IF; Leite TJA; Lima GRM; Barbosa-Filho JM; Tavares JF; Silva MSD; Athayde-Filho PF; Batista LM
    Int J Mol Sci; 2012; 13(3):3203-3228. PubMed ID: 22489149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peptic ulcer due to Helicobacter pylori].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):832-6. PubMed ID: 9648433
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapy of Helicobacter pylori infection in peptic ulcer disease (first part)].
    Boixeda De Miquel D; Martín De Argila C
    Rev Clin Esp; 2002 Sep; 202(9):492-4. PubMed ID: 12236940
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K; Kato T; Sakagawa T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives.
    Spósito L; Oda FB; Vieira JH; Carvalho FA; Dos Santos Ramos MA; de Castro RC; Crevelin EJ; Crotti AEM; Santos AG; da Silva PB; Chorilli M; Bauab TM
    J Ethnopharmacol; 2019 Apr; 233():1-12. PubMed ID: 30594606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.
    Liou JM; Chen CY; Wu MS; Hsu MT; Fang CC; Lin YL; Chang MC; Lin JT; Wang HP
    Hepatogastroenterology; 2006; 53(71):792-6. PubMed ID: 17086891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
    Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
    Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.
    Tytgat GN
    Aliment Pharmacol Ther; 1994 Aug; 8(4):359-68. PubMed ID: 7986961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptic ulcer disease in liver cirrhosis: role of Helicobacter pylori infection and therapeutic approach].
    Mitrică D; Constantinescu R; Drug VL; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):27-32. PubMed ID: 21688556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic-ulcer disease.
    Chan FK; Leung WK
    Lancet; 2002 Sep; 360(9337):933-41. PubMed ID: 12354485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.